Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3Liver Neoplasms 2Liver Diseases 2Stomach Neoplasms 1Primary Graft Dysfunction 1Neoplasms 1Liver Failure, Acute 1Liver Failure 1Gastrointestinal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Adenocarcinoma 1

Interventions

veliparib 1urinastatin 1maltodextrin 1halofantrine 1Taxes 1Raltegravir Potassium 1Paclitaxel 1N-monoacetylcystine 1Hepatectomy 1Glycyrrhizic Acid 1Everolimus 1Carboplatin 1Blood Specimen Collection 1Amino Acids 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Failure × halofantrine × Gastrointestinal × Clear all
NCT01394497 2013-02-18

Use of N-Acetylcysteine During Liver Procurement

Azienda Ospedaliera di Padova

Phase 2 Completed
140 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Liver Failure, Liver Failure, Acute, Primary Graft Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡